← back to search

Xingyan Ou

Guangzhou University of Chinese Medicine · CN
Area of research
Obstetrics and Gynecology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Meta-analysis and Drug delivery, with related work in Abortion, Pulmonary disease, Nanotechnology. Notable publications include 'The state-of-art polyurethane nanoparticles for drug delivery applications', 'Efficacy and safety of Chinese patent medicines combined with conventional therapies for endometriosis: A systematic review and bayesian network meta-analysis', and 'Comparative effectiveness of low molecular weight heparin on live birth for recurrent spontaneous abortion: systematic review and network meta-analysis'.
h-index
citations
39
works
7
NIH funding
primary concept
email

Recent publications

Efficacy and safety of Chinese patent medicines combined with conventional therapies for endometriosis: A systematic review and bayesian network meta-analysis
Journal of Ethnopharmacology 2025cited by 9position: middledoi
Postoperative Adjuvant Treatments for Cervical Cancer: A Network Meta-Analysis
International Journal of Radiation Oncology*Biology*Physics 2025cited by 0position: middledoi
The state-of-art polyurethane nanoparticles for drug delivery applications
Frontiers in Chemistry 2024cited by 15position: middledoi
Comparative effectiveness of low molecular weight heparin on live birth for recurrent spontaneous abortion: systematic review and network meta-analysis
American Journal of Obstetrics & Gynecology MFM 2024cited by 7position: middledoi
Comparing robotic, laparoscopic, and laparotomy in endometrial cancer: a network meta-analysis
International Journal of Surgery 2024cited by 4position: middledoi
Comparative effectiveness of Statins for Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension: systematic review and network meta-analysis
Research Square 2024cited by 0position: middledoi
Comparative efficacy of acupuncture-related interventions for tubal obstructive infertility: A systematic review and Bayesian meta-analysis of randomized controlled trials
Complementary Therapies in Medicine 2023cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xingzi Fang · Guangzhou University of Chinese Medicine7 papers (2023–2025)Wenrui Huang · Guangzhou University of Chinese Medicine5 papers (2023–2025)Xiaoxuan Tang · Guangzhou University of Chinese Medicine5 papers (2024–2025)Lei Chen · Wuhan Polytechnic University5 papers (2024–2025)XueLian Du · Guangzhou University of Chinese Medicine4 papers (2023–2025)Jing Ling · Guangzhou University of Chinese Medicine3 papers (2023–2025)Xuelian Du · Guangzhou University of Chinese Medicine3 papers (2024–2025)Yue Yu · Guangzhou University of Chinese Medicine2 papers (2024–2025)Bing Guo · National University of Singapore1 papers (2024–2024)Yinghe Zhang · Wenzhou Medical University1 papers (2024–2024) · 1 papers (2024–2024)Saz Muhammad · Twitter (United States)1 papers (2024–2024)Siying Dang · Guangzhou University of Chinese Medicine1 papers (2024–2024)Wenrui Huang · John Brown University1 papers (2025–2025)Tianyun Liu · Palo Alto University1 papers (2025–2025)Guo‐Bo Xu · University of Arizona1 papers (2024–2024)Wencong Song · Guangzhou University of Chinese Medicine1 papers (2024–2024)